Codon Adaptation for Therapeutic Protein Cell Line Development
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating cell lines that produce therapeutic proteins are time-consuming and require high concentrations of toxic selection and amplification agents, leading to instability and increased costs, as well as potential toxicity risks for operators.
Innovation Solution
The use of codon adaptation to enhance the codon adaptation index (CAI) of open reading frames encoding therapeutic proteins, reducing the need for selection and amplification agents and shortening the time required for cell line development, while maintaining or improving protein production yields.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional selection and amplification methods are used to generate cell lines, then protein production yield is improved, but development time increases and toxic agent concentrations must be increased
Solution Approach 1:
The patent applies preliminary action by pre-optimizing the codon adaptation index of expression cassettes before cell line development. By designing expression cassettes with maximized codon adaptation to the host cell species beforehand, the invention eliminates the need for time-consuming iterative selection and amplification cycles, directly achieving high protein production while reducing development time
Solution Approach 2:
The patent applies parameter changes by modifying the codon adaptation index parameter of expression cassettes. By changing the nucleotide sequence composition to optimize codon usage patterns matching the host cell's tRNA pool, the invention improves translation efficiency and protein yield without requiring increased toxic agent concentrations or extended development periods
2Productivity
If amplification cycles are increased to improve protein yield, then production plateau is approached, but exposure to toxic selection agents increases
Solution Approach 1:
The patent applies preliminary action by pre-optimizing expression cassette design with maximum codon adaptation before cell line development begins. This upfront optimization eliminates the need for multiple amplification cycles using toxic agents like methotrexate, achieving high protein yields while minimizing operator exposure to harmful substances
Solution Approach 2:
The patent converts the potential harm of toxic selection agents into benefit by designing expression cassettes that achieve amplification-like effects through codon optimization alone. The maximized codon adaptation creates efficient translation that naturally produces high protein yields without requiring toxic agents, turning the problem of toxicity into an opportunity for safer, more efficient expression system design
3Productivity
If selection pressure is increased to select for high producers, then protein titre improves, but protocol complexity and cost increase
Solution Approach 1:
The patent applies parameter changes by modifying the codon adaptation index parameter of expression cassettes to match the host cell's optimal codon usage. This single parameter optimization simplifies the overall protocol by eliminating multiple selection and amplification steps, reducing both complexity and cost while achieving high protein titres through improved translation efficiency
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention provides methods of reducing the levels of a titratable selectable pressure required, the number of amplification cycles, and the time taken to generate protein expressing cell lines by altering the codons of the desired open-reading-frames. Through the use of codon adaptation for this purpose the methods of the invention consistently provide sufficient yields in faster time frames saving many weeks in cell line development activities. Furthermore the methods of the invention also generate cell lines with lower concentrations of selection and amplification agent than previously achievable. Accordingly lower levels of selection and amplification marker in the final cells lines are observed.